4.7 Article

Shikonin impedes phase separation and aggregation of tau and protects SH-SY5Y cells from the toxic effects of tau oligomers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Contrasting Effects of Ferric and Ferrous Ions on Oligomerization and Droplet Formation of Tau: Implications in Tauopathies and Neurodegeneration

Sandipan Mukherjee et al.

Summary: The dysregulation of ferric ions leads to enhanced aggregation of tau protein, with Fe3+ decreasing the critical concentration required for liquid-liquid phase separation of tau and significantly increasing the formation of tau oligomers and fibrils. Fe3+ binds to tau with higher affinity compared to Fe2+ and disrupts the secondary structure of tau, favoring tau aggregation by increasing beta-sheet content and decreasing disordered content. Fe3+ may enhance non-covalent interactions between disordered domains of tau molecules, ultimately leading to tau aggregation and pointing to a potential relationship between dysregulation of ferric ions and neurodegenerative disorders.

ACS CHEMICAL NEUROSCIENCE (2021)

Review Clinical Neurology

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation

Carolina Alquezar et al.

Summary: Post-translational modifications play a crucial role in regulating tau protein function, including phosphorylation and acetylation. While these modifications may regulate protein function under normal conditions, they can be hijacked in disease states. Limited understanding exists on how these modifications impact tau protein, but studies indicate their critical role in localization, interactions, and other aspects.

FRONTIERS IN NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

C1 Inhibits Liquid-Liquid Phase Separation and Oligomerization of Tau and Protects Neuroblastoma Cells against Toxic Tau Oligomers

Arpan Pradhan et al.

Summary: C1, a synthetic derivative of curcumin, strongly inhibits the aggregation and filament formation of tau, protects neuroblastoma cells from the deleterious effects of tau oligomers, and reduces the mean diameter and quantity of tau oligomers.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

The Acetyl Mimicking Mutation, K274Q in Tau, Enhances the Metal Binding Affinity of Tau and Reduces the Ability of Tau to Protect DNA

Jitendra Subhash Rane et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

The antidepressant drug; trazodone inhibits Tau amyloidogenesis: Prospects for prophylaxis and treatment of AD

Vali Akbari et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)

Review Neurosciences

Targeting tau: Clinical trials and novel therapeutic approaches

Lawren VandeVrede et al.

NEUROSCIENCE LETTERS (2020)

Review Biochemistry & Molecular Biology

Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies

Anuradha Venkatramani et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)

Review Geriatrics & Gerontology

Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects

Pascale Barbier et al.

FRONTIERS IN AGING NEUROSCIENCE (2019)

Review Pathology

Molecular Pathogenesis of the Tauopathies

Jurgen Gotz et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14 (2019)

Review Cell Biology

Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides

Guru KrishnaKumar Viswanathan et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Tau protein liquid-liquid phase separation can initiate tau aggregation

Susanne Wegmann et al.

EMBO JOURNAL (2018)

Review Clinical Neurology

Tau-targeting therapies for Alzheimer disease

Erin E. Congdon et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Medicine, Research & Experimental

Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules

Jennifer N. Rauch et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)

Article Neurosciences

Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro

Jitendra Subhash Rane et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Review Neurosciences

Propagation of Tau aggregates

Michel Goedert et al.

MOLECULAR BRAIN (2017)

Article Cell Biology

Effect of Shikonin on Spinal Cord Injury in Rats Via Regulation of HMGB1/TLR4/NF-κB Signaling Pathway

Yihui Bi et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Clinical Neurology

Roles of tau protein in health and disease

Tong Guo et al.

ACTA NEUROPATHOLOGICA (2017)

Review Clinical Neurology

Tau and neurodegenerative disease: the story so far

Khalid Iqbal et al.

NATURE REVIEWS NEUROLOGY (2016)

Review Neurosciences

Tau in physiology and pathology

Yipeng Wang et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Review Clinical Neurology

Neuropathology of tauopathies: principles and practice

G. G. Kovacs

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)

Article Multidisciplinary Sciences

A mechanistic model of tau amyloid aggregation based on direct observation of oligomers

Sarah L. Shammas et al.

NATURE COMMUNICATIONS (2015)

Article Clinical Neurology

Structure and Mechanism of Action of Tau Aggregation Inhibitors

Katryna Cisek et al.

CURRENT ALZHEIMER RESEARCH (2014)

Article Nutrition & Dietetics

Evaluation of radical scavenging properties of shikonin

Lucia S. Yoshida et al.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2014)

Article Multidisciplinary Sciences

Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein

Simon Dujardin et al.

PLOS ONE (2014)

Review Clinical Neurology

Formation and propagation of tau oligomeric seeds

Julia E. Gerson et al.

FRONTIERS IN NEUROLOGY (2013)

Article Biochemistry & Molecular Biology

Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

Cristian A. Lasagna-Reeves et al.

FASEB JOURNAL (2012)

Article Pharmacology & Pharmacy

Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity

Zhenhua Wang et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2010)

Review Neurosciences

Tau protein and tau aggregation inhibitors

Bruno Bulic et al.

NEUROPHARMACOLOGY (2010)

Review Chemistry, Multidisciplinary

Development of Tau Aggregation Inhibitors for Alzheimer's Disease

Bruno Bulic et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)

Article Multidisciplinary Sciences

Differential regulation of dynein and kinesin motor proteins by tau

Ram Dixit et al.

SCIENCE (2008)

Article Instruments & Instrumentation

WSXM: A software for scanning probe microscopy and a tool for nanotechnology

I. Horcas et al.

REVIEW OF SCIENTIFIC INSTRUMENTS (2007)

Review Neurosciences

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

Carlo Ballatore et al.

NATURE REVIEWS NEUROSCIENCE (2007)

Article Biochemistry & Molecular Biology

Global hairpin folding of tau in solution

S Jeganathan et al.

BIOCHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

S Taniguchi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

M Pickhardt et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Multidisciplinary Sciences

Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease

D Panda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)